Oric Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -320 | -310 | -302 | |
EBITDA | -30,185 | -32,299 | -38,754 | -32,416 |
EBIT | -30,505 | -32,587 | -39,064 | -32,718 |
Net Income | -30,505 | -32,587 | -36,355 | -30,021 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -22,870 | -25,147 | -30,905 | -33,162 |
Cash | 45,669 | 49,668 | 75,864 | 49,334 |
Basic Shares | 87,793 | 98,953 | 78,126 | 71,040 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,220 | -1,107 | -1,032 | -966 |
EBITDA | -128,248 | -126,740 | -109,748 | -85,801 |
EBIT | -129,468 | -127,847 | -110,780 | -86,767 |
Net Income | -129,468 | -127,847 | -100,697 | -89,122 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -159,166 | |||
Free Cash Flow | -114,079 | -113,850 | -86,537 | -77,221 |
Cash | 45,669 | 59,406 | 23,384 | 66,840 |
Basic Shares | 87,793 | 69,727 | 51,450 | 39,655 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.30 |
2025-09-30 | -$0.33 |
2025-06-30 | -$0.47 |
